VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib.
Saved in:
| Title: | VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib. |
|---|---|
| Authors: | Kuiper JL (AUTHOR), Lind JS (AUTHOR), Groen HJ (AUTHOR), Roder J (AUTHOR), Grigorieva J (AUTHOR), Roder H (AUTHOR), Dingemans AM (AUTHOR), Smit EF (AUTHOR), Kuiper, J L1 (AUTHOR), Lind, J S W (AUTHOR), Groen, H J M (AUTHOR), Roder, J (AUTHOR), Grigorieva, J (AUTHOR), Roder, H (AUTHOR), Dingemans, A M C (AUTHOR), Smit, E F (AUTHOR) |
| Source: | British Journal of Cancer. 11/20/2012, Vol. 107 Issue 11, p1820-1825. 6p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/bjc.2012.470 |
